Kymera Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·WATERTOWN, MA·FY end 12/31·CIK 1815442

Board of Directors

9 members · 7 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Bruce Booth, D.Phil.	Chair	11y	51	—	—	—
Nello Mainolfi, Ph.D.	CEO and Director	7y	47	—	—	—
John Maraganore, Ph.D.	Director	4y	63	—		—
Elena Ridloff, CFA	Director	5y	46	—		—
Pamela Esposito, Ph.D.	Director	6y	52	—		—
Gorjan Hrustanovic, Ph.D.	Director	6y	37	—		—
Victor Sandor, M.D.C.M.	Director	4y	59	—		—
Jeffrey Albers, J.D., MBA	Director	6y	54	—		—
Felix J. Baker, Ph.D.	Lead Independent Director	2y	57	—		—

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.